Results 181 to 190 of about 332,373 (294)

Diagnostic performance of plasma D-dimer, fibrinogen, and D-dimer to fibrinogen ratio as potential biomarkers to predict hypertension-associated acute ischemic stroke

Heliyon
Background: Ischemic stroke is a common type of stroke that leads to death and functional disability in hypertensive patients. However, there are no well-studied non-invasive and less expensive fluid biomarkers routinely used to detect ischemic stroke in
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie, Denekew Tenaw Anley, Misganaw Asmamaw Mengstie, Natnael Atnafu Gebeyehu, Getachew Asmare Adella, Gizachew Ambaw Kassie, Natnael Amare Tesfa, Molalegn Mesele Gesese, Sefineh Fenta Feleke, Melkamu Aderajew Zemene, Anteneh Mengist Dessie, Wubet Alebachew Bayih, Yenealem Solomon Kebede, Berihun Bantie, Mohammed Abdu Seid, Engidaw Fentahun Enyew, Gashaw Dessie, Dagnew Getnet Adugna, Teklie Mengie Ayele, Assefa Agegnehu Teshome, Fitalew Tadele Admasu   +21 more
doaj  

Emerging Targeted Delivery Strategies of Nanosystems for Ischemic Stroke Treatment. [PDF]

Int J Nanomedicine
Ren JX, Ma HY, Yin WJ, Li YK, Lei SY, Liu JC, Yang Y, Guo ZN.   +7 more
europepmc   +1 more source

Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group.

, 1999
Roger X. You, Amanda G. Thrift, John J. McNeil, Stephen M. Davis, Geoffrey A. Donnan   +4 more
openalex   +2 more sources

Predicting Early Deterioration or Improvement in Ischemic Stroke by Transcranial Doppler [PDF]

, 1998
Raymond Tak Fai Cheung
openalex   +1 more source

Genetic data do not provide evidence that lower sclerostin is associated with increased risk of atherosclerosis: comment on the article by Zheng et al

Arthritis &Rheumatology, EarlyView.
James R. Staley, Olga Giannakopoulou, Gill Holdsworth, Martin Armstrong   +3 more
wiley   +1 more source

Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI—A Proof‐of‐Concept Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Up to 50% of patients with ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD). Aims This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post ...
Roberto Scarsini, Denis Leonardi, Andrea Bottardi, Concetta Mammone, Leonardo Portolan, Caterina Butturini, Verdiana Galli, Francesco Della Mora, Alessandro Ruzzarin, Sara Pazzi, Anna Piccoli, Simone Fezzi, Domenico Tavella, Gabriele Pesarini, Leonardo Gottin, Flavio Ribichini   +15 more
wiley   +1 more source

Neutrophil extracellular traposis in cancer patients with acute ischemic stroke. [PDF]

PLoS One
Hyun JW, Payumo RMP, Chung J, Kang YR, Kim SH, Kim HJ, Han JY, Park SY.   +7 more
europepmc   +1 more source

Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy, Annette Min, Edward O. McFalls, Robert A. Perera, Fadi N. Salloum, Ion S. Jovin   +5 more
wiley   +1 more source

The Role of IL-6 in Ischemic Stroke. [PDF]

Biomolecules
Pawluk H, Woźniak A, Tafelska-Kaczmarek A, Kosinska A, Pawluk M, Sergot K, Grochowalska R, Kołodziejska R.   +7 more
europepmc   +1 more source

A Case Series of Valve‐in‐Valve Transcatheter Aortic Valve Replacement in Stentless Bioprosthetic Valves Using Self‐Expanding Platform With Minimalist Approach

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Valve‐in‐valve (ViV) Transcatheter aortic valve replacement (TAVR) has emerged as a valid treatment option in symptomatic patients with failed aortic bioprosthetic valves, most especially in those with intermediate, high or prohibitive risk of surgery. Due to the unique design of stentless bioprosthetic valves with absence of visible posts and
Adeogo Akinwale Olusan, Raj Rajendra, Elved Roberts, Jan Kovac   +3 more
wiley   +1 more source